Public emergencies, including pandemics, natural disasters, and armed conflicts, pose significant challenges to the provision of fertility care. Disruptions in healthcare infrastructure, reallocation of resources, and heightened psychosocial stressors impact both access and outcomes in assisted reproductive technologies (ART) and general fertility services. This review synthesizes recent research and clinical guidance on managing fertility care during public emergencies, highlighting epidemiology, pathophysiological considerations, risk factors, diagnostic and management strategies, as well as emerging therapeutic directions. We aim to equip clinicians with evidence-based, practical insights to optimize reproductive care in crisis contexts.
The delivery of fertility care is uniquely vulnerable during public emergencies. Events such as the COVID-19 pandemic, major natural disasters, and conflicts disrupt healthcare systems, strain resources, and force prioritization of acute and critical care over elective services like ART. For individuals and couples seeking fertility treatment, these disruptions can have profound biological, psychological, and socioeconomic consequences. Understanding the multidimensional impact of emergencies on fertility care is essential for clinicians to provide effective, empathetic, and evidence-guided management. This article reviews the current landscape, integrating recent clinical findings, mechanistic insights, and professional guidelines relevant to fertility care in crisis settings.
Globally, approximately one in six couples experiences infertility, with millions depending on ART or medical management. During public emergencies, the burden of untreated or delayed infertility care increases substantially. For example, data from the COVID-19 pandemic revealed a marked reduction in fertility clinic activity, with up to 85% of clinics worldwide suspending new ART cycles in early 2020. Natural disasters and conflicts have also been associated with reduced ART access and increased unmet reproductive health needs. The cumulative effect is a growing backlog of patients, exacerbated psychological distress, and potentially worsened reproductive outcomes due to advancing age or disease progression.
Public emergencies may impact fertility through direct and indirect mechanisms. Infectious agents, as seen with SARS-CoV-2, can affect gonadal function, gamete quality, and endometrial receptivity. Systemic illnesses, pyrexia, and inflammatory states can transiently suppress hypothalamic-pituitary-gonadal axis function. Chronic stress, common during emergencies, elevates cortisol and can impair ovulatory cycles and spermatogenesis. Additionally, delayed access to medical interventions may allow progression of underlying gynecological or andrological disorders, further complicating the pathophysiological landscape.
Certain populations are at increased risk for poor fertility outcomes during public emergencies. Advanced maternal age, diminished ovarian reserve, pre-existing reproductive endocrinopathies (e.g., PCOS, endometriosis), and male factor infertility may all amplify the impact of delayed care. Socioeconomic disadvantage, limited healthcare access, and geographic barriers further compound risk, particularly in low-resource settings or among displaced populations. Psychological vulnerability, including pre-existing mental health disorders, can also negatively affect treatment adherence and outcomes.
The clinical presentation of fertility patients during public emergencies often reflects both biological and psychosocial dimensions. Delayed cycles, irregular menstruation, and exacerbation of underlying reproductive pathology (e.g., ovarian cysts, fibroids) are common. Patients may also present with increased anxiety, depressive symptoms, and relationship stressors. Additionally, disruptions in routine monitoring or medication access can precipitate complications such as ovarian hyperstimulation syndrome or suboptimal ART response.
Accurate diagnosis during public emergencies is challenged by resource constraints and infection control protocols. Telemedicine has emerged as a valuable tool for initial assessment, triage, and ongoing monitoring. Laboratory testing and imaging may be limited or delayed, necessitating prioritization of urgent cases. Clinicians must maintain a high index of suspicion for acute complications (e.g., ectopic pregnancy, ovarian torsion) and adapt protocols to minimize in-person visits without compromising diagnostic accuracy. Psychosocial screening should be integrated into initial and follow-up encounters to address mental health comorbidities.
Management strategies during public emergencies emphasize individualized care, risk mitigation, and resource stewardship. Elective ART cycles may be deferred based on local epidemiology and healthcare system capacity. Where treatment proceeds, protocols should minimize patient exposure (e.g., using antagonist cycles, trigger adjustments), enhance infection control, and ensure continuity of medication supply. Emergency fertility preservation (e.g., oocyte or sperm cryopreservation) remains a priority for oncology patients and those at risk of imminent gonadal damage. Multidisciplinary coordination, including mental health support, is critical for optimizing outcomes.
Recent advances have focused on leveraging technology and refining clinical pathways. Telehealth platforms now enable remote consultation, cycle monitoring, and patient education, reducing physical visits. Innovations in ovarian stimulation protocols, such as random-start and progestin-primed approaches, offer flexibility in cycle initiation and scheduling. Point-of-care testing and mobile ultrasound devices have expanded access in resource-limited or high-risk settings. Furthermore, research into the reproductive impact of emerging pathogens, such as SARS-CoV-2, continues to inform risk assessment and management.
Professional societies, including ASRM, ESHRE, and IFFS, have issued dynamic guidance for fertility care during public emergencies. Key recommendations include triaging patients based on urgency (e.g., fertility preservation, age-related decline), implementing stringent infection prevention measures, and utilizing telemedicine where feasible. Risk communication, informed consent, and contingency planning for cycle cancellation are emphasized. Societies advocate for equitable access to care and prioritization of psychosocial support throughout the crisis period.
The provision of fertility care during public emergencies demands adaptability, multidisciplinary collaboration, and evidence-based practice. While significant challenges exist, recent advances and evolving guidelines enable clinicians to mitigate risks and optimize outcomes for patients seeking reproductive assistance. Ongoing research, innovative care models, and policy advocacy are essential to ensure resilience and equity in fertility care amid future emergencies.
1.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
2.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
3.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
4.
Daily physical activity, even at light intensities, linked to lower cancer risk
5.
PSA Often Unchanged With Enzalutamide Progression
1.
Oncology Communication Training for Difficult Conversations
2.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
3.
Unlocking Life Expectancy After Subdural Hematoma: A New Hope
4.
The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology
5.
Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation